文献速递瓣膜病与结构性心脏病

显著瓣膜病女性的妊娠结局:系统综述与荟萃分析

Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis.
PubMed 文献 · Heart · 2020-02-13

重度二尖瓣狭窄孕妇死亡率为3%,肺水肿37%;重度主动脉瓣狭窄孕妇死亡率为2%,肺水肿9%。中度/重度二尖瓣狭窄和主动脉瓣狭窄孕妇均面临不良母胎结局风险,应接受孕前咨询及有妊娠与心脏病经验团队的管理。

要点

  • 重度二尖瓣狭窄孕妇死亡率3%,肺水肿37%,新发/复发心律失常16%。
  • 重度主动脉瓣狭窄孕妇死亡率2%,肺水肿9%,新发/复发心律失常4%。
  • 中度/重度二尖瓣狭窄和主动脉瓣狭窄孕妇应接受孕前咨询及专业团队管理。

核心结论

  • 中度/重度二尖瓣狭窄和主动脉瓣狭窄孕妇存在不良母胎结局风险。
  • 应接受孕前咨询及由具有妊娠与心脏病经验团队提供的孕期照护。

研究设计与样本

  • 系统综述与荟萃分析,检索OvidSP平台数据库(1985年至2019年1月)。

主要发现

  • 重度二尖瓣狭窄孕妇死亡率为3%(95%CI 0%-6%),肺水肿37%(23%-51%),新发/复发心律失常16%(1%-25%)。
  • 重度二尖瓣狭窄孕妇死产率4%(1%-7%),新生儿死亡率2%(0%-4%),早产率18%(7%-29%)。
  • 中度二尖瓣狭窄孕妇死亡率1%(0%-2%),肺水肿18%(2%-33%),新发/复发心律失常5%(1%-9%),死产2%(1%-4%),早产10%(2%-17%)。
  • 重度主动脉瓣狭窄孕妇死亡率2%(0%-5%),肺水肿9%(2%-15%),新发/复发心律失常4%(0%-7%),死产2%(0%-5%),新生儿死亡率3%(0%-6%),早产率14%(4%-24%)。
  • 中度主动脉瓣狭窄孕妇无母体/新生儿死亡报告,肺水肿8%(0%-20%),新发/复发心律失常2%(0%-5%),早产13%(6%-20%)。

临床怎么用

  • 对中度/重度二尖瓣狭窄或主动脉瓣狭窄的育龄女性应提供孕前咨询。
  • 孕期照护应由具有妊娠与心脏病管理经验的团队负责。

局限性

  • 合并发生率及95%CI仅能基于涉及二尖瓣狭窄或主动脉瓣狭窄的研究计算。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform a systematic review and meta-analysis of maternal/fetal outcomes in pregnant women with moderate/severe native valvular heart disease (VHD) from medium/higher Human Development Index (HDI) countries. METHODS: OvidSP platform databases were searched (1985-January 2019) to identify studies reporting pregnancy outcomes in women with moderate/severe VHD. The primary maternal outcome was maternal mortality. The primary fetal/neonatal outcome was stillbirth and neonatal death. Pooled incidences and 95% confidence intervals (CI) of maternal/fetal outcomes could only be calculated from studies involving mitral stenosis (MS) or aortic stenosis (AS). RESULTS: Twelve studies on 646 pregnancies were included. Pregnant women with severe MS had mortality rates of 3% (95% CI, 0% to 6%), pulmonary oedema 37% (23%-51%) and new/recurrent arrhythmias 16% (1%-25%). Their stillbirth, neonatal death and preterm birth rates were 4% (1%-7%), 2% (0%-4%), and 18% (7%-29%), respectively. Women with moderate MS had mortality rates of 1%(0%-2%), pulmonary oedema 18% (2%-33%), new/recurrent arrhythmias 5% (1%-9%), stillbirth 2% (1%-4%) and preterm birth 10%(2%-17%).Pregnant women with severe AS had a risk of mortality of 2% (0%-5%), pulmonary oedema 9% (2%-15%), and new/recurrent arrhythmias 4% (0%-7%). Their stillbirth, neonatal death and preterm birth rates were 2% (0%-5%), 3% (0%-6%) and 14%(4%-24%), respectively. No maternal/neonatal deaths were reported in moderate AS, however women experienced pulmonary oedema (8%; 0%-20%), new/recurrent arrhythmias (2%; 0%-5%), and preterm birth (13%; 6%-20%). CONCLUSIONS: Women with moderate/severe MS and AS are at risk for adverse maternal and fetal/neonatal outcomes. They should receive preconception counseling and pregnancy care by teams with pregnancy and heart disease experience.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ducas RA, Javier DA, D'Souza R, et al. Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis. Heart. 2020. PMID: 32054673. doi:10.1136/heartjnl-2019-315859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。